Recurrent Breast Cancer Active Not Recruiting Phase 2 Trials for Sorafenib (DB00398)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT026247002nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast CancerTreatment